CARGO Therapeutics, Inc. (CRGX) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for CARGO Therapeutics, Inc. (CRGX).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $4.46

Daily Change: -$0.02 / 0.45%

Daily Range: $4.45 - $4.49

Market Cap: $207,465,824

Daily Volume: 715,413

Performance Metrics

1 Week: -0.67%

1 Month: 1.59%

3 Months: 5.44%

6 Months: 22.19%

1 Year: -73.29%

YTD: -69.07%

Company Details

Employees: 167

Sector: Health technology

Industry: Biotechnology

Country:

Details

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, focused on designing, engineering, and developing potentially curative cell therapies for cancer patients in the United States. The company develops CRG-023, a tri-specific CAR T product candidate which is in phase 1 that targets tumor cells with three B-cell malignancies; and allogeneic platform, a universal vector solution designed to effectively limit immune-based rejection to enable durable response of CAR T-cell therapy. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is based in San Carlos, California.

Selected stocks

Sprott Inc. (SII)

Standard Lithium Ltd. (SLI)

Brookfield Finance Inc. 4.625% Subordinated Notes due October 16, 2080 (BNH)